BioXcel Therapeutics Inc (BTAI) stock news · rev $642.0K
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
This BTAI news page leads with what BioXcel Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for BTAI yet. We will not pad this page with generic market recap.
Latest reported BTAI revenue for 2025-12-31 was $642.0K. Net income was -$69.9M. Revenue was down 71.7% from 2024-12-31 to 2025-12-31. BTAI currently screens at market cap $36.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BTAI stock page; for the tape open the quote page.
BTAI stock news FAQ
What are BTAI's latest revenue and net income?
Latest cached BioXcel Therapeutics Inc (BTAI) revenue for Dec 31, 2025 was $642.0K. Net income was -$69.9M. Statements: https://lician.com/financials/btai
How did BTAI revenue change from the prior cached period?
Cached BioXcel Therapeutics Inc (BTAI) revenue was down 71.7% from $2.3M (Dec 31, 2024) to $642.0K (Dec 31, 2025). Statements: https://lician.com/financials/btai
What is BTAI's market cap?
BioXcel Therapeutics Inc (BTAI) market cap is $36.1M on the latest cached fundamentals snapshot.
What kind of company is BTAI?
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Where is BTAI stock news listed?
Cached stock news for BioXcel Therapeutics Inc (BTAI) is listed at https://lician.com/news/btai. Filings: https://lician.com/sec/btai
Not investment advice.